Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer | Synapse
February 13, 2023Open Access
Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer
Key Points
Key points are not available for this paper at this time.
Abstract
Analysis of tumor DNA in plasma and urine samples both separately and combined has a potential to predict treatment response and outcome.